(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
a peptide approved for clinical use) and GLP-1 (purple), respectively
What Makes A Professional Facial Different From At-Home Skincare
You feel slightly queasy, particularly in the morning or after eating, but you can still function
GLP-1 Treatments, Semaglutide or Tirzepatide is a medication developed to help individuals struggling with obesity manage their weight more effectively